Porcine reproductive and respiratory syndrome virus vaccines: Immunogenicity, efficacy and safety aspects.

@article{Charerntantanakul2012PorcineRA,
  title={Porcine reproductive and respiratory syndrome virus vaccines: Immunogenicity, efficacy and safety aspects.},
  author={Wasin Charerntantanakul},
  journal={World journal of virology},
  year={2012},
  volume={1 1},
  pages={23-30}
}
Porcine reproductive and respiratory syndrome virus (PRRSV) infection is the leading cause of economic casualty in swine industry worldwide. The virus can cause reproductive failure, respiratory disease, and growth retardation in the pigs. This review deals with current status of commercial PRRS vaccines presently used to control PRRS. The review focuses on the immunogenicity, protective efficacy and safety aspects of the vaccines. Commercial PRRS modified-live virus (MLV) vaccine elicits… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 26 extracted citations

Improved Vaccine against PRRSV: Current Progress and Future Perspective

Front. Microbiol. • 2017
View 7 Excerpts
Highly Influenced

Safety and efficacy of a novel European vaccine for porcine reproductive and respiratory virus in bred gilts.

Canadian journal of veterinary research = Revue canadienne de recherche veterinaire • 2016
View 10 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…